CAH vs IPCXR · P/E 35, rev $254.25B vs rev $100.0M
Cardinal Health Inc (CAH) versus Inflection Point Acquisition Corp. III Rights (IPCXR) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Inflection Point Acquisition Corp. III Rights (IPCXR) common stock listed on US.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported IPCXR revenue for 2025-09-30 was $100.0M. Net income was -$90.8K. IPCXR currently screens at market cap $0.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. IPCXR currently screens at market cap $0.
Not investment advice. Open the CAH and IPCXR stock pages for the full models.
Not investment advice.